With good compatibility and targeting, the product can be used in combination with chemotherapeutic agents, immunotherapeutic drugs, etc., showing synergistic effects in preclinical studies
Jastreboff AM et al., Phase 2 retatrutide, NEJM 2023 (NEJMoa2301972, PMID 37366315) -24,2% at 48 weeks at the 12 mg level
Theo mt nghin cu cng b trn National Library Medicine, s dng thc phm giu selen s gip tng cng hot ng ca cht chng oxy ha Glutathione
Crosstalk between microglia and astrocytes via NF-B, NLRP3 inflammasome, and the signaling pathway STAT3 enhances cytokine cascades, contributing to BBB collapse
However, emerging therapies like Tirzepatide offer potential benefits beyond glucose regulation
OSullivan, K